Aditya Birla Sun Life Pharma and Healthcare Fund vs Motilal Oswal BSE Healthcare ETF
Direct Plan where a fund has one, Growth option · Data as on 30-10-2026
Aditya Birla Sun Life Pharma and Healthcare Fund is a Thematic fund and Motilal Oswal BSE Healthcare ETF is an ETF fund. In the 3 years to 30-10-2026, Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) returned 21.1% a year and Motilal Oswal BSE Healthcare ETF returned 22.7% a year. Aditya Birla Sun Life Pharma and Healthcare Fund charges 1.08% a year and Motilal Oswal BSE Healthcare ETF 0.36%. Their portfolios overlap 53.8%: they hold 36 of the same securities.
Aditya Birla Sun Life Pharma and Healthcare Fund
Thematic
- 3 year return
- 21.1%
- Expense ratio
- 1.08%
- NAV
- ₹39.28
Motilal Oswal BSE Healthcare ETF
ETF
- 3 year return
- 22.7%
- Expense ratio
- 0.36%
- NAV
- ₹50.91
Which is better, Aditya Birla Sun Life Pharma and Healthcare or Motilal Oswal BSE Healthcare ETF? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Motilal Oswal BSE Healthcare ETF returned more over 3 years: 22.7% a year against 21.1%.
- Aditya Birla Sun Life Pharma and Healthcare returned more over 1 year: 14.2% against 12.2%.
- Motilal Oswal BSE Healthcare ETF costs less: 0.36% a year against 1.08%.
- Aditya Birla Sun Life Pharma and Healthcare swung less over 3 years: a standard deviation of 12.8% a year against 14.1%.
- Aditya Birla Sun Life Pharma and Healthcare fell less in its worst fall since 04-08-2022: −15.9% against −16.1%.
- Aditya Birla Sun Life Pharma and Healthcare is the larger fund: ₹1,078 Cr against ₹44 Cr.
- Their portfolios overlap 53.8%: 36 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Aditya Birla Sun Life Pharma and Healthcare Fund | Motilal Oswal BSE Healthcare ETF |
|---|---|---|
| Fund house | Aditya Birla Sun Life Mutual Fund | Motilal Oswal Mutual Fund |
| Category | Thematic | ETF |
| AUM | ₹1,078 Cr (30-09-2026) | ₹44 Cr (30-09-2026) |
| NAV | ₹39.28 (Direct) | ₹50.91 |
| Expense ratio (Direct) | 1.08% | Not available |
| Expense ratio (Regular) | 2.31% | Not available |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | BSE Healthcare TRI |
| Launch date | 11-07-2019 | 29-07-2022 |
| Minimum investment | ₹1,000 | ₹500 |
| Lock in | None | None |
| Fund managers | Dhaval Shah | Swapnil Mayekar, Rakesh Shetty |
| Exit load | Exit load of 1% if redeemed within 30 days. | Nil |
Aditya Birla Sun Life Pharma and Healthcare vs Motilal Oswal BSE Healthcare ETF: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | −1.11% | −2.63% | +12.00% | +14.15% | +21.08% | +14.76% | -- |
| Motilal Oswal BSE Healthcare ETF | +0.22% | −1.05% | +12.72% | +12.16% | +22.69% | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | +11.62% | -- |
Category average: the average of the 235 Thematic funds, same plan type.
Aditya Birla Sun Life Pharma and Healthcare vs Motilal Oswal BSE Healthcare ETF: Year-wise Returns
| Year | Aditya Birla Sun Life Pharma and HealthcareAditya Birla Sun Life Pharma and Healthcare | Motilal Oswal BSE Healthcare ETFMotilal Oswal BSE Healthcare ETF | BSE Healthcare TRI |
|---|---|---|---|
| 2026to date | +15.94% | +14.90% | +15.08% |
| 2025 | −3.09% | −2.93% | −2.72% |
| 2024 | +37.69% | +43.80% | +44.30% |
| 2023 | +39.58% | +37.59% | +37.97% |
| 2022 | −11.31% | -- | −11.50% |
| 2021 | +21.36% | -- | +21.54% |
Aditya Birla Sun Life Pharma and Healthcare vs Motilal Oswal BSE Healthcare ETF: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of both
Rolling returns
Every 3-year holding period, 305 of them, one for each trading day from 04-08-2025 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Motilal Oswal BSE Healthcare ETF
BSE Healthcare TRI
to
Sept 2025Nov 2022
to
Nov 2025Feb 2023
to
Feb 2026Apr 2023
to
Apr 2026Jul 2023
to
Jul 2026Sept 2023
to
Sept 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare | 0.0 | 0.0 | 0.0 | 0.0 | 3.3 | 80.7 | 16.1 | 23.4% | 23.4% | 18.5% | 27.8% | 0% |
| Motilal Oswal BSE Healthcare ETF | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 72.5 | 25.9 | 24.1% | 24.2% | 19.5% | 28.4% | 0% |
| BSE Healthcare TRI | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 63.3 | 36.1 | 24.4% | 24.6% | 19.8% | 28.8% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is BSE Healthcare TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 04-08-2022. Past returns do not promise future returns.
Aditya Birla Sun Life Pharma and Healthcare vs Motilal Oswal BSE Healthcare ETF: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 01-08-2022 to 30-10-2026: 51 instalments, ₹5,10,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and HealthcareAditya Birla Sun Life Pharma and Healthcare Fund (Direct) | ₹5,10,000 | ₹7,51,035 | ₹2,41,035 | 18.4% |
| Motilal Oswal BSE Healthcare ETFMotilal Oswal BSE Healthcare ETF | ₹5,10,000 | ₹7,62,270 | ₹2,52,270 | 19.2% |
Aditya Birla Sun Life Pharma and HealthcareAditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Motilal Oswal BSE Healthcare ETFMotilal Oswal BSE Healthcare ETF
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
Aditya Birla Sun Life Pharma and Healthcare vs Motilal Oswal BSE Healthcare ETF: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | Motilal Oswal BSE Healthcare ETF |
|---|---|---|
| Return (CAGR) | +14.15% | +12.16% |
| Standard deviation | 12.28% | 13.58% |
| Sharpe ratio | 0.73 | 0.51 |
| Sortino ratio | 1.07 | 0.75 |
| Maximum drawdown | −9.6% (23-10-2026) | −10.0% (23-10-2026) |
| Beta | 0.87 | 1.00 |
| Alpha | +2.70% | −0.20% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | Motilal Oswal BSE Healthcare ETF |
|---|---|---|
| Return (CAGR) | +21.08% | +22.69% |
| Standard deviation | 12.82% | 14.08% |
| Sharpe ratio | 1.17 | 1.18 |
| Sortino ratio | 1.69 | 1.68 |
| Maximum drawdown | −15.9% (28-02-2025) | −16.1% (28-02-2025) |
| Beta | 0.87 | 1.00 |
| Alpha | +0.27% | −0.28% |
From daily NAVs, 30-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | Motilal Oswal BSE Healthcare ETF |
|---|---|---|
| Return (CAGR) | +20.52% | +20.31% |
| Standard deviation | 14.89% | 13.22% |
| Sharpe ratio | 1.03 | 1.07 |
| Sortino ratio | 1.51 | 1.54 |
| Maximum drawdown | −20.5% (17-06-2022) | −16.1% (28-02-2025) |
| Beta | 0.88 | 1.00 |
| Alpha | +1.23% | −0.29% |
From daily NAVs, 11-07-2019 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Motilal Oswal BSE Healthcare ETF
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | −15.9% | 09-10-2024 | 28-02-2025 | 05-05-2026 | 14 months | −4.7% |
| Motilal Oswal BSE Healthcare ETF | −16.1% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −3.8% |
| BSE Healthcare TRI | −16.2% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −3.8% |
From daily values since 04-08-2022, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Motilal Oswal BSE Healthcare ETF
BSE Healthcare TRI
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 3-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Motilal Oswal BSE Healthcare ETF
BSE Healthcare TRI
Against BSE Healthcare TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | 94% | 90% | 3.84% |
| Motilal Oswal BSE Healthcare ETF | 99% | 100% | 0.06% |
From month-end values since 04-08-2022. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
Aditya Birla Sun Life Pharma and Healthcare vs Motilal Oswal BSE Healthcare ETF: Portfolio Overlap
From each fund's latest monthly portfolio: Aditya Birla Sun Life Pharma and Healthcare Fund, September 2026; Motilal Oswal BSE Healthcare ETF, September 2026
Holdings in common
- Overlap
- 53.8%
- Held by both
- 36
- Only in Aditya Birla Sun Life Pharma and Healthcare
- 3
- Only in Motilal Oswal BSE Healthcare ETF
- 101
| Security | % of Aditya Birla Sun Life Pharma and Healthcare | % of Motilal Oswal BSE Healthcare ETF |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 8.61% | 12.33% |
| Apollo Hospitals Enterprise Ltd. | 6.44% | 5.21% |
| Cipla Ltd. | 6.38% | 4.79% |
| Torrent Pharmaceuticals Ltd. | 9.28% | 3.55% |
| Lupin Ltd. | 2.94% | 3.11% |
| Aurobindo Pharma Ltd. | 4.52% | 2.89% |
| Fortis Healthcare Ltd. | 2.42% | 2.51% |
| Divi's Laboratories Ltd. | 2.24% | 7.42% |
| Mankind Pharma Ltd. | 3.62% | 1.75% |
| IPCA Laboratories Ltd. | 2.71% | 1.69% |
| Alkem Laboratories Ltd. | 1.68% | 1.89% |
| Biocon Ltd. | 1.45% | 1.63% |
| Gland Pharma Ltd. | 2.70% | 1.44% |
| Sai Life Sciences Ltd. | 4.49% | 1.30% |
| Dr. Reddy's Laboratories Ltd. | 1.13% | 4.73% |
| Ajanta Pharma Ltd. | 4.35% | 1.02% |
| Dr. Lal Path labs Ltd. | 3.51% | 0.96% |
| Abbott India Ltd. | 3.26% | 0.87% |
| Piramal Pharma Ltd. | 1.22% | 0.81% |
| Shilpa Medicare Ltd. | 1.43% | 0.77% |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.83% | 0.71% |
| Max Healthcare Institute Ltd. | 0.60% | 4.32% |
| Anthem Biosciences Ltd. | 1.13% | 0.58% |
| Emcure Pharmaceuticals Ltd. | 3.21% | 0.51% |
| Jubilant Pharmova Ltd. | 0.60% | 0.51% |
| Natco Pharma Ltd. | 0.92% | 0.46% |
| Vijaya Diagnostic Centre Ltd. | 1.04% | 0.45% |
| Syngene International Ltd. | 0.64% | 0.43% |
| Pfizer Ltd. | 1.01% | 0.37% |
| Metropolis Healthcare Ltd. | 1.48% | 0.36% |
| Jupiter Life Line Hospitals Ltd. | 1.55% | 0.30% |
| Procter & Gamble Health Ltd. | 1.82% | 0.28% |
| Corona Remedies Ltd. | 2.27% | 0.25% |
| Thyrocare Technologies Ltd. | 1.76% | 0.21% |
| Sanofi Consumer Healthcare India Ltd. | 1.11% | 0.16% |
| Suraksha Diagnostic Ltd. | 1.10% | 0.04% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 53.8% means 53.8% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Aditya Birla Sun Life Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Manipal Health Enterprises Ltd | 1.07% |
| Medi Assist Healthcare Services Ltd. | 0.73% |
| Vinati Organics Ltd. | 0.69% |
Largest holdings only in Motilal Oswal BSE Healthcare ETF
| Security | % of fund |
|---|---|
| Laurus Labs Limited | 4.84% |
| Glenmark Pharmaceuticals Limited | 2.17% |
| Zydus Lifesciences Limited | 1.82% |
| Krishna Institute Of Medical Sciences Limited | 1.24% |
| Aster DM Quality Care Limited | 1.18% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Aditya Birla Sun Life Pharma and Healthcare | Motilal Oswal BSE Healthcare ETF |
|---|---|---|
| Equity | 97.9% | 99.9% |
| Debt | 0.0% | 0.0% |
| Cash and others | 2.1% | 0.1% |
Market cap of stocks
| Market cap | Aditya Birla Sun Life Pharma and Healthcare | Motilal Oswal BSE Healthcare ETF |
|---|---|---|
| Large Cap | 32.9% | 33.3% |
| Mid Cap | 30.6% | 38.5% |
| Small Cap | 31.7% | 27.8% |
| Not on AMFI's list | 2.6% | 0.3% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Aditya Birla Sun Life Pharma and Healthcare | Motilal Oswal BSE Healthcare ETF |
|---|---|---|
| Pharmaceuticals & Biotechnology | 74.9% | 78.0% |
| Healthcare Services | 21.6% | 21.4% |
| Insurance | 0.7% | 0.0% |
| Chemicals & Petrochemicals | 0.7% | 0.0% |
| Healthcare Equipment & Supplies | 0.0% | 0.5% |
The six largest sectors of each fund's stocks, % of the fund.
Aditya Birla Sun Life Pharma and Healthcare vs Motilal Oswal BSE Healthcare ETF: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Aditya Birla Sun Life Pharma and Healthcare Fund | Motilal Oswal BSE Healthcare ETF |
|---|---|---|
| Total expense ratio (Direct) | 1.08% | Not available |
| Base expense ratio (Direct) | 0.84% | 0.00% |
| Total expense ratio (Regular) | 2.31% | Not available |
| Base expense ratio (Regular) | 1.91% | 0.21% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Aditya Birla Sun Life Pharma and Healthcare with
- Aditya Birla Sun Life Pharma and Healthcare vs Nippon India Taiwan Equity
- Aditya Birla Sun Life Pharma and Healthcare vs HDFC Defence
- Aditya Birla Sun Life Pharma and Healthcare vs HDFC Pharma and Healthcare
- Aditya Birla Sun Life Pharma and Healthcare vs SBI Healthcare Opportunities
- Aditya Birla Sun Life Pharma and Healthcare vs Aditya Birla Sun Life International Equity
Aditya Birla Sun Life Pharma and Healthcare Fund vs Motilal Oswal BSE Healthcare ETF: Frequently Asked Questions
What is the difference between Aditya Birla Sun Life Pharma and Healthcare Fund and Motilal Oswal BSE Healthcare ETF?
Aditya Birla Sun Life Pharma and Healthcare Fund is a Thematic fund, Motilal Oswal BSE Healthcare ETF is an ETF fund, run by Aditya Birla Sun Life Mutual Fund and Motilal Oswal Mutual Fund. Their portfolios overlap 53.8%. Aditya Birla Sun Life Pharma and Healthcare Fund charges 1.08% a year and Motilal Oswal BSE Healthcare ETF 0.36%.
Which has given higher returns, Aditya Birla Sun Life Pharma and Healthcare Fund or Motilal Oswal BSE Healthcare ETF?
Over 1 year: Aditya Birla Sun Life Pharma and Healthcare Fund +14.15%, Motilal Oswal BSE Healthcare ETF +12.16%. Over 3 years: Aditya Birla Sun Life Pharma and Healthcare Fund +21.08% a year, Motilal Oswal BSE Healthcare ETF +22.69% a year. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, Aditya Birla Sun Life Pharma and Healthcare Fund or Motilal Oswal BSE Healthcare ETF?
Motilal Oswal BSE Healthcare ETF charges less: 0.36% a year against 1.08%. These are the total expense ratios reported to AMFI.
How much do Aditya Birla Sun Life Pharma and Healthcare Fund and Motilal Oswal BSE Healthcare ETF overlap?
53.8%. They hold 36 of the same securities, the largest shared ones being SUNPHARMA, APOLLOHOSP, CIPLA. From each fund's latest monthly portfolio.
Which is riskier, Aditya Birla Sun Life Pharma and Healthcare Fund or Motilal Oswal BSE Healthcare ETF?
On SEBI's riskometer, Aditya Birla Sun Life Pharma and Healthcare Fund is rated Very High and Motilal Oswal BSE Healthcare ETF Very High. Over 3 years, the standard deviation of daily returns was 12.82% and 14.08% a year.
Which is better for SIP, Aditya Birla Sun Life Pharma and Healthcare Fund or Motilal Oswal BSE Healthcare ETF?
Over the last 3 years, a monthly SIP of ₹10,000 from 03-10-2023 to 30-10-2026 grew to ₹4,57,489 in Aditya Birla Sun Life Pharma and Healthcare Fund (XIRR 13.9% a year) and ₹4,63,433 in Motilal Oswal BSE Healthcare ETF (XIRR 14.8% a year). Both received 37 instalments. Past returns do not promise future returns.
Can I invest in both Aditya Birla Sun Life Pharma and Healthcare Fund and Motilal Oswal BSE Healthcare ETF?
Yes. 53.8% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Who manages Aditya Birla Sun Life Pharma and Healthcare Fund and Motilal Oswal BSE Healthcare ETF?
Aditya Birla Sun Life Pharma and Healthcare Fund: Dhaval Shah. Motilal Oswal BSE Healthcare ETF: Swapnil Mayekar, Rakesh Shetty.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.